Location, location, location: where should you build your biobusiness?
26 August, 2002 by David BinningThe most important concept for Australian biotechnology companies to grasp when building a nest, according to industry and property development experts, is proximity.
US VC warns of early IPO dangers
23 August, 2002 by Melissa TrudingerDon't go public too early, use incubators to get your company off the ground and maximise collaborative opportunities, were the key messages from US venture capitalist Peter Morgan Kash at the AusBiotech 2002 conference this week.
Second BIF grant gives Protagonist an edge
22 August, 2002 by Pete YoungFor drug design start-up Protagonist, tucking a second BIF grant in as many years under its belt should help smooth future discussions with commercial partners.
Heavy R&D spend sees Antisense book $6.3m loss
22 August, 2002 by David BinningBiopharmaceutical research and development company Antisense Therapeutics reported on Wednesday a net loss of $6.3 million for the 12 months to June 30, 2002, driven largely by heavy early-stage expenditure on R&D, the company said.
IDT posts profit record number eight
22 August, 2002 by David BinningAustralian drug discovery company International Drug Technologies has announced a record 14 per cent jump in full year net profit to $4.2 million.
Put your pedal to the metal: BIO chief
20 August, 2002 by Melissa TrudingerIt's time for biobusiness to accelerate without looking back, the chair of the US Biotechnology Industry Organisation (BIO), David Robinson, told the AusBiotech conference in Melbourne this week.
Chemeq tops Deloitte WA index
19 August, 2002 by Iain ScottWestern Australian biotech Chemeq has topped a Deloitte Touche Tohmatsu index highlighting the market performance of WA listed companies over the last two years.
Peacock to head Fed research advisory panel
16 August, 2002 by Iain ScottCSIRO Plant Industry chief Dr Jim Peacock has been selected to head the Federal government's advisory panel on national research priorities.
Careers in chemistry
16 August, 2002 by Claire DobleA presentation on Careers for Chemists in Biotechnology, scheduled for Monash University next fortnight, has proved popular.
Synchrotron debate heats up
15 August, 2002 by Melissa TrudingerVictorian Treasurer and Innovation Minister John Brumby went on the defensive today after newspapers reported that the Victorian government had approached the Federal government to bail them out of the $57 million hole in the Synchrotron project.
Iatia restructures, gears up for sales
15 August, 2002 by Melissa TrudingerMelbourne based company Iatia has announced changes to its management structure to capitalise on the development of new industrial applications for its imaging technology.
X-ray scientist joins Queensland Institute
14 August, 2002 by Pete YoungAustralia's small community of X-ray crystallographers has been strengthened with the arrival of protein crystallography specialist Dr Helen Blanchard at the Centre for Biomolecular Science and Drug Discovery.
HK biotech maverick tipped to open in Melbourne
14 August, 2002 by David BinningAsia's wealthiest tycoon, Li Ka Shing, is poised for a major foray into the Australian biotechnology sector with the top brass from his newly floated biotech interest CK Life Sciences meeting with senior Victorian government officials in Beijing this week.
Forensic science feature: from the textbooks to the courts
13 August, 2002 by Melissa TrudingerWhile forensic scientists used to use blood typing and other methods to identify crime suspects, DNA identification and profiling is now the method of choice. Since its first use in an Australian court in 1989, the technology has moved from the controversial to the mainstream, although controversy still rages around the issue of creating databases of DNA profiles for criminal identification.
Nanotechnology researcher wins Victoria Fellowship
13 August, 2002 by Melissa TrudingerRMIT research fellow Dr Gary Rosengarten is one of six recipients of this year's Victoria Fellowships, awarded to emerging leaders in science, engineering and technology.
